Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Bronchodilator response in patients with normal baseline spirometry.

Hegewald MJ, Townsend RG, Abbott JT, Crapo RO.

Respir Care. 2012 Oct;57(10):1564-70. Epub 2012 Mar 12.

2.

Long-term intersession variability for single-breath diffusing capacity.

Hegewald MJ, Jensen RL, Teeter JG, Wise RA, Riese RJ, England RD, Ahrens RC, Crapo RO, MacIntyre NR.

Respiration. 2012;84(5):377-84. doi: 10.1159/000334699. Epub 2011 Dec 31.

3.

The need to change the method for defining mild airway obstruction.

Quanjer PH, Enright PL, Miller MR, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP, Jensen RL.

Eur Respir J. 2011 Mar;37(3):720-2. doi: 10.1183/09031936.00135110. No abstract available.

4.

Respiratory physiology in pregnancy.

Hegewald MJ, Crapo RO.

Clin Chest Med. 2011 Mar;32(1):1-13. doi: 10.1016/j.ccm.2010.11.001. Review.

PMID:
21277444
5.

[Open letter to the members of the GOLD committee].

Le groupe Pulmonaria, Quanjer PH, Enright PL, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP, Jensen RL; ANZSRS : Australian and New Zealand Society of Respiratory; ARTP : Association for Respiratory Technology and Physiology; CAHAG : COPD and Astma Huisartsen Advies Groep (COPD and Asthma GP Advisory Group); SKL : Dutch Paediatric Repiratory Society; Education for Health, Warwick, UK; National Respiratory Training Center, Virginia, US; NHG : Nederlands Huisartsen Genootschap (Dutch Society of GPs); NVALT : Nederlandse Vereniging van Artsen voor Longziekten en Tuberculose (Dutch Thoracic Society); NVLA : Nederlandse Vereniging Longfunctie Analisten (Dutch Society of Respiratory Technicians); PCRS-UK : Primary Care Respiratory Society UK; Société de Physiologie; SPLF : Société de pneumologie de langue franc¸aise; SSMG : Société scientifique de médecine générale; WONCA: World Organization of Family Doctors.

Rev Mal Respir. 2010 Nov;27(9):1003-7. doi: 10.1016/j.rmr.2010.09.007. Epub 2010 Oct 8. French. No abstract available.

PMID:
21111268
6.

Open letter: the need to change the method for defining mild airway obstruction.

Quanjer PH, Enright PL, Miller MR, Stocks J, Ruppel G, Swanney MP, Crapo RO, Pedersen OF, Falaschetti E, Schouten JP; Pulmonaria Group.

Prim Care Respir J. 2010 Sep;19(3):288-91. doi: 10.4104/pcrj.2010.00052. No abstract available.

7.

Spirometry guidelines influence lung function results in a longitudinal study of young adults.

Smith LJ, Arynchyn A, Kalhan R, Williams OD, Jensen R, Crapo R, Jacobs DR Jr.

Respir Med. 2010 Jun;104(6):858-64. doi: 10.1016/j.rmed.2009.12.006. Epub 2010 Jan 4.

8.

The measure of treatment agreement between portable and laboratory blood gas measurements in guiding protocol-driven ventilator management.

Thomas FO, Hoffman TL, Handrahan DL, Crapo RO, Snow G.

J Trauma. 2009 Aug;67(2):303-13; discussion 313-4. doi: 10.1097/TA.0b013e3181a5f055.

PMID:
19667883
9.

Prevalence of airway obstruction in recreational SCUBA divers.

Weaver LK, Churchill SK, Hegewald MJ, Jensen RL, Crapo RO.

Wilderness Environ Med. 2009 Summer;20(2):125-8. doi: 10.1580/08-WEME-OR-226R1.1.

PMID:
19594212
10.

Reference values for lung volumes in an Iranian population: introducing a new equation model.

Golshan M, Amra B, Soltani F, Crapo RO.

Arch Iran Med. 2009 May;12(3):256-61.

11.

Quality control of DL,CO instruments in global clinical trials.

Jensen R, Leyk M, Crapo R, Muchmore D, Berclaz PY.

Eur Respir J. 2009 Apr;33(4):828-34. doi: 10.1183/09031936.00091208. Epub 2009 Jan 7.

12.

Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource.

Teerlink CC, Camp NJ, Bansal A, Crapo R, Hughes D, Kort E, Rowe K, Cannon-Albright LA.

Eur J Hum Genet. 2009 May;17(5):636-43. doi: 10.1038/ejhg.2008.236. Epub 2008 Dec 17.

13.

The impact of diabetes and age on pulmonary function: data from the National Health and Nutrition Examination Survey.

Berclaz PY, Gao H, Tobian JA, Swanson DL, Webb DM, Crapo RO, Jensen RL.

Diabetes Res Clin Pract. 2009 Jan;83(1):e1-3. doi: 10.1016/j.diabres.2008.09.043. Epub 2008 Nov 20.

PMID:
19022514
14.

Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.

Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH.

Thorax. 2008 Dec;63(12):1046-51. doi: 10.1136/thx.2008.098483. Epub 2008 Sep 11.

PMID:
18786983
15.

Clinical measurements of membrane diffusing capacity and pulmonary capillary blood volume.

Crapo RO.

Chest. 2008 Sep;134(3):479. doi: 10.1378/chest.08-1390. Epub 2008 Jun 26. No abstract available.

PMID:
18583510
16.

Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease.

Drummond MB, Schwartz PF, Duggan WT, Teeter JG, Riese RJ, Ahrens RC, Crapo RO, England RD, Macintyre NR, Jensen RL, Wise RA.

Am J Respir Crit Care Med. 2008 Aug 1;178(3):225-32. doi: 10.1164/rccm.200801-090OC. Epub 2008 May 8.

17.

Longitudinal association of body mass index with lung function: the CARDIA study.

Thyagarajan B, Jacobs DR Jr, Apostol GG, Smith LJ, Jensen RL, Crapo RO, Barr RG, Lewis CE, Williams OD.

Respir Res. 2008 Apr 4;9:31. doi: 10.1186/1465-9921-9-31.

18.

Definition of COPD: based on evidence or opinion?

Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, Macintyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.

Eur Respir J. 2008 Mar;31(3):681-2. doi: 10.1183/09031936.00154307. No abstract available.

19.

Socioeconomic status and lung function.

Hegewald MJ, Crapo RO.

Chest. 2007 Nov;132(5):1608-14. Review.

PMID:
17998360
20.

Diagnosis of COPD.

Falaschetti E, Swanney MP, Crapo RO, Hankinson JL, Jensen RL, Pedersen OF, Quanjer PH, Ruppel GL, Schouten JP.

Thorax. 2007 Oct;62(10):924-5; author reply 925. No abstract available.

21.

Standardization of the single-breath diffusing capacity in a multicenter clinical trial.

Wise RA, Teeter JG, Jensen RL, England RD, Schwartz PF, Giles DR, Ahrens RC, MacIntyre NR, Riese RJ, Crapo RO.

Chest. 2007 Oct;132(4):1191-7. Epub 2007 Sep 21.

PMID:
17890472
22.

Pulmonary function changes related to acute and chronic administration of inhaled insulin.

Hegewald M, Crapo RO, Jensen RL.

Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S93-S101. Review.

PMID:
17563309
23.

Defining the lower limit of normal for FEV1/ FVC.

Miller MR, Steenbruggen I, Quanjer PH, Ruppel G, Crapo RO, Pedersen OF.

Am J Respir Crit Care Med. 2007 Jul 1;176(1):101; author reply 101-2. No abstract available.

PMID:
17586765
24.

Instrument accuracy and reproducibility in measurements of pulmonary function.

Jensen RL, Teeter JG, England RD, White HJ, Pickering EH, Crapo RO.

Chest. 2007 Aug;132(2):388-95. Epub 2007 Jun 15.

PMID:
17573502
25.

Arm span as an independent predictor of pulmonary function parameters: validation and reference values.

Golshan M, Crapo RO, Amra B, Jensen RL, Golshan R.

Respirology. 2007 May;12(3):361-6.

PMID:
17539839
26.

Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design.

Jensen RL, Teeter JG, England RD, Howell HM, White HJ, Pickering EH, Crapo RO.

Chest. 2007 Aug;132(2):396-402. Epub 2007 Mar 30.

PMID:
17400686
27.

Peak expiratory flow is not a quality indicator for spirometry: peak expiratory flow variability and FEV1 are poorly correlated in an elderly population.

Hegewald MJ, Lefor MJ, Jensen RL, Crapo RO, Kritchevsky SB, Haggerty CL, Bauer DC, Satterfield S, Harris T.

Chest. 2007 May;131(5):1494-9. Epub 2007 Mar 30.

PMID:
17400677
28.

[Coming together: the ATS/ERS consensus on clinical pulmonary function testing].

Brusasco V, Crapo R, Viegi G.

Rev Mal Respir. 2007 Mar;24(3 Pt 2):2S11-4. French. No abstract available.

PMID:
17389836
29.

A statistical rationale for the use of forced expired volume in 6 s.

Jensen RL, Crapo RO, Enright P.

Chest. 2006 Dec;130(6):1650-6.

PMID:
17166978
30.

The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.

Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG.

COPD. 2005 Jun;2(2):277-83. Review.

PMID:
17136954
31.

Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.

Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB.

Thorax. 2006 Jan;61(1):10-6. Epub 2005 Nov 11.

32.

Periodontitis and airway obstruction.

Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO, Jensen R, Waterer G, Rubin SM, Newman AB.

J Periodontol. 2005 Nov;76(11 Suppl):2161-7.

PMID:
16277589
33.

Interpretative strategies for lung function tests.

Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J.

Eur Respir J. 2005 Nov;26(5):948-68. No abstract available.

34.

Periodontitis and Airway Obstruction.

Katancik JA, Kritchevsky S, Weyant RJ, Corby P, Bretz W, Crapo RO, Jensen R, Waterer G, Rubin SM, Newman AB.

J Periodontol. 2005 Nov;76 Suppl 11S:2161-2167. doi: 10.1902/jop.2005.76.11-S.2161.

PMID:
29539036
35.

Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J.

Eur Respir J. 2005 Oct;26(4):720-35. No abstract available.

36.

Role of reference values in making medical decisions.

Crapo RO.

Indian J Med Res. 2005 Aug;122(2):100-2. No abstract available.

PMID:
16177465
37.

Standardisation of the measurement of lung volumes.

Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G.

Eur Respir J. 2005 Sep;26(3):511-22. Review. No abstract available.

38.

The role of FEV6 in the detection of airway obstruction.

Crapo RO.

Respir Med. 2005 Nov;99(11):1467. Epub 2005 Aug 10. No abstract available.

39.

Standardisation of spirometry.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Aug;26(2):319-38. No abstract available.

40.

General considerations for lung function testing.

Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force.

Eur Respir J. 2005 Jul;26(1):153-61. Review. No abstract available.

41.

Coming together: the ATS/ERS consensus on clinical pulmonary function testing.

Brusasco V, Crapo R, Viegi G; American Thoracic Society; European Respiratory Society.

Eur Respir J. 2005 Jul;26(1):1-2. Review. No abstract available.

42.
43.

The role of reference values in interpreting lung function tests.

Crapo RO.

Eur Respir J. 2004 Sep;24(3):341-2. No abstract available.

44.

Spirometric reference values for the 6-s FVC maneuver.

Hankinson JL, Crapo RO, Jensen RL.

Chest. 2003 Nov;124(5):1805-11.

PMID:
14605052
45.

Spirometric reference values in a large Middle Eastern population.

Golshan M, Nematbakhsh M, Amra B, Crapo RO.

Eur Respir J. 2003 Sep;22(3):529-34. Erratum in: Eur Respir J. 2004 Feb;23(2):356.

46.

Diffusing capacity: how to get it right.

Jensen RL, Crapo RO.

Respir Care. 2003 Aug;48(8):777-82. Review.

47.

Standards and interpretive issues in lung function testing.

Crapo RO, Jensen RL.

Respir Care. 2003 Aug;48(8):764-72. Review.

48.

Airway inflammation in COPD: physiological outcome measures and induced sputum.

Crapo RO, Jensen RL, Hargreave FE.

Eur Respir J Suppl. 2003 Jun;41:19s-28s. Review.

49.

A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study.

Wilk JB, DeStefano AL, Arnett DK, Rich SS, Djousse L, Crapo RO, Leppert MF, Province MA, Cupples LA, Gottlieb DJ, Myers RH.

Am J Respir Crit Care Med. 2003 Jun 1;167(11):1528-33. Epub 2003 Mar 13.

PMID:
12637344
50.

Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.

Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R, McKenzie D, Magnussen H.

J Allergy Clin Immunol. 2003 Jan;111(1):45-50.

PMID:
12532095

Supplemental Content

Support Center